Marta Siernicka - Concepedia

Author

Marta Siernicka

Also Known As

M Siernicka, Marta Siernicka

Publications

435

Citations

H-Index

Concepts

All Affiliations

Marta Siernicka is an author at Medical University of Warsaw specializing in tumor microenvironment, immunology, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	42
2	Cell Biology	2	2	42
3	Immunology	2	2	42
4	Pharmacology	1	1	22
5	Immunotherapy	1	1	20

Marta Siernicka

Publications

303

Citations

H-Index

Page 1

	Year	Citations
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk‐Jarzynka, Cancer Immunology Research	2018	106
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents Małgorzata Bajor, Agata O. Zych, Agnieszka Graczyk‐Jarzynka, British Journal of Cancer	2018	62
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies Małgorzata Bobrowicz, Michal Dwojak, Beata Pyrzyńska, Blood	2017	50
FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy Beata Pyrzyńska, Michal Dwojak, Abdessamad Zerrouqi, OncoImmunology	2018	32
Adenanthin, a new inhibitor of thiol‐dependent antioxidant enzymes, impairs the effector functions of human natural killer cells Marta Siernicka, Magdalena Winiarska, Małgorzata Bajor, Immunology Lipid PeroxidationImmunologyNk CellsCell DeathCellular Pharmacology	2015	22
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies Magdalena Winiarska, Kamil Bojarczuk, Beata Pyrzyńska, mAbs Tumor BiologyCancer ImmunosurveillanceSfks InhibitorsMedicineImmunology	2014	20
Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells Karolina Janyst, Michał Janyst, Marta Siernicka, Oncology Reports	2018	11

Page 1